More than 12% of physicians do not have managed care contracts, but the break down varies by situation
In 2008, 87% of physicians had managed care contracts, according to the Center for Studying Health System Change (HSC) 2008 Health Tracking Physician Survey, funded by the Robert Wood Johnson Foundation. Compared with physicians with one or more managed care contracts, physicians without managed care contracts were more likely to have practiced for more than 20 years, work fewer than 40 hours per week, lack board certification, work in solo or two-physician practices, live in the western United States and report practicing in a "non-competitive" environment.
"Physicians still don't like managed care, but they continue to lose the ability to do anything about it," Heller says.
On a positive note, Heller tells Managed Healthcare Executive: "Managed care companies have become much more physician-friendly and physician-oriented. They have come to realize that it is cooperation and not competition that works best for both parties."
DOLLAR-DRIVEN DECISIONS
Physicians' clinical decisions determine how up to 90 cents of every healthcare dollar is spent, according to Cassil.
Paul Keckley, executive director, Deloitte Center for Health Solutions, believes that much attention is being paid to the emergent role of consumers as active participants in clinical decisions, and physicians remain the dominant influence on health expenditures and drive most costs directly, however, "the 90% is a bit high."
The managed care community needs to better understand physician concerns, according to Heller.
"Involve community physicians in the managed care plan's policy and operational matters," he says. "Participate in physician training opportunities at medical schools and hospitals; hire locally, and train and support local physician leadership."
Keckley says plans should be candid with physicians, using reliable facts and hard data to influence behavior.
"Physicians are generally frustrated and fearful about the future," he says. "They want to be respected. They want to be seen as professionals and be free of intrusion by managed care. That said, they respond to tools, not rules, and the most meaningful tools are those that help them make better judgments about patient care."
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More